Get started
Author

Ulugbek I. Nizamov

Observed names: Nizamov U. I., Nizamov, U.I., U Nizamov, U. I. Nizamov, U. Nizamov, U.I. Nizamov, Ulugbek I Nizamov, Ulugbek Nizamov, У Низамов
ORCID: 0000-0001-6171-7652
Observed ORCID: 0000-0001-6171-7652
OpenAlex ID: A5075460863
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021 · Antonio J. Vallejo-Vaz, Christophe A.T. Stevens, et al. · The Lancet · 354
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
2023 · Kanika Inamdar Dharmayat, Antonio J. Vallejo-Vaz, et al. · The Lancet · 100
PDF
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024 · Amany Elshorbagy, Alexander R.M. Lyons, et al. · The Lancet Diabetes & Endocrinology · 17
Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?
2019 · Aleksandr B. Shek, Rano B. Alieva, et al. · Archives of Medical Science - Atherosclerotic Diseases · 12
PDF
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease
2017 · Aleksandr B. Shek, Ravshanbek D. Kurbanov, et al. · Archives of Medical Science - Atherosclerotic Diseases · 11
PDF
Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle
2018 · Aleksandr Shek, Rano Alieva, et al. · Atherosclerosis · 6
TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice
2022 · Krzysztof J. Filipiak, Miguel Camafort Babkowski, et al. · Cardiology Journal · 5
PDF
Personalized rosuvastatin therapy in problem patients with partial statin intolerance
2018 · Aleksandr B. Shek, Ravshanbek D. Kurbanov, et al. · Archives of Medical Science - Atherosclerotic Diseases · 4
PDF
Study of main arteries stiffness in patients with coronary heart disease depending on prevalence of atherosclerosis
2016 · U.I. Nizamov, F.M. Bekmetova, et al. · Cor et Vasa · 3
PDF
The Relationship between the Parameters of Blood Pressure Variability and Arterial Wall Stiffness in Patients with Arterial Hypertension
2019 · Nigora Tursunova, Ulugbek Nizamov, et al. · International Journal of Biomedicine · 2
PDF
Relationship between coronary atherosclerotic lesion and arterial stiffness in patients with coronary artery disease
2024 · D Yusupalieva, A Shek, et al. · European Heart Journal · 1
PDF
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice
2023 · Krzysztof J. Filipiak, Vivencio Barrios, et al. · Cardiology Journal · 1
PDF
Gender Differences in 10-Year Mortality in Patients with Coronary Artery Disease with Elevated Lipoprotein(a): In Search of Invisible Guardian Angel
2022 · Aleksandr B Shek, Rano B Alieva, et al. · International Journal of Biomedicine · 1
PDF
Connection of the Genetic Polymorphism Cyp3a5 and Slco1b1 With the Muscular Symptoms, Caused by Simvastatin in Patients With Chd, Ethnic Uzbeks: Results of the Case-control Study
2017 · B.B. Shek, R.D. Kurbanov, et al. · Siberian medical review · 1
PDF
Complex Evaluation Parameters of Central Aortic Blood Pressure and Main Arteries Stiffness in Patients With Coronary Artery Disease, Depending on the Prevalence of Atherosclerosis
2015 · U. I. Nizamov, F. M. Bekmetova, et al. · Eurasian heart journal · 1
PDF
Genetic yield of next-generation sequencing for detecting monogenic familial hypercholesterolemia in uzbek patients with coronary artery disease
2026 · Rano B. Alieva, Aleksandr B. Shek, et al. · PLoS ONE
PDF
Targeted DNA Sequencing of LDLR, APOB, PCSK9, and LDLRAP1 Using QIAseq DNA Pro Custom Panel and Illumina MiSeq v1
2026 · Rano Alieva, Aleksandr Shek, et al.
PDF
Comparative analysis of cardiometabolic parameters in patients with coronary heart disease with and without non-alcoholic fatty liver disease
2025 · Dilnora B. Yusupalieva, Rano B. Alieva, et al. · Exploration of Cardiology
PDF
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024
2025 · Krzysztof J. Filipiak, Matteo Cameli, et al. · Cardiology Journal
PDF
Роль Микрорнк В Патогенезе Атеросклероза: Новые Горизонты Исследований
2024 · Д Юсупалиева, У Низамов, et al. · Cardiology of Uzbekistan.
PDF
Роль Микрорнк В Патогенезе Атеросклероза: Новые Горизонты Исследований
2024 · Д Юсупалиева, У Низамов, et al. · Cardiology of Uzbekistan.
Nonalcoholic Fatty Liver Disease Is a Cornerstone of the Cardiovascular Continuum
2024 · Yusupalieva D. B., Nizamov U. I., et al. · Journal of Medical Genetics and Clinical Biology
PDF
Роль микрорнк в патогенезе атеросклероза: новые горизонты исследований
2024 · Д Юсупалиева, У Низамов, et al. · Cardiology of Uzbekistan.
PDF
STRUGGLE FOR. Włosko-polsko-hiszpańsko-uzbecko-wietnamskie Stanowisko Ekspertów 2023 dotyczące lepszej kontroli klasycznych modyfikowalnych czynników ryzyka w praktyce klinicznej
2023 · Krzysztof J. Filipiak, Vivencio Barrios, et al. · Choroby Serca i Naczyń
Assessment of CYS681Xpolymorphisn of LDL receptor gene’s impact on lipid metabolism in patients with familian hypercholesterolemia
2021 · R.B. Alieva, A.B. Shek, et al. · Atherosclerosis
Works count: 34
Citation count: 519
H-index: 6
I10-index: 5
Year
Topic
Type